Dipexium Pharmaceuticals, Inc. (DPRX) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 8 transactions totaling $182.0K, demonstrating a bullish sentiment with $182.0K in net insider flow. The most recent transaction on May 21, 2014 involved a purchase of 3,000 shares valued at $27.0K.
No significant insider buying has been recorded for DPRX in the recent period.
No significant insider selling has been recorded for DPRX in the recent period.
Based on recent SEC filings, insider sentiment for DPRX is bullish with an Insider Alignment Score of 100/100 and a net flow of $182.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Dipexium Pharmaceuticals, Inc. (DPRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading DPRX stock, having executed 8 transactions in the past 90 days. The most active insider is Jack H. Dean (Executive), who has made 2 transactions totaling $52.0K.
Get notified when executives and directors at DPRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 21, 2014 | H. Dean Jack | Executive | Purchase | 3,000 | $9.00 | $27.0K | |
| Mar 18, 2014 | J. Deluccia Robert | Executive | Purchase | 2,083 | $12.00 | $25.0K | |
| Mar 18, 2014 | Garrett David | Executive | Purchase | 2,083 | $12.00 | $25.0K | |
| Mar 18, 2014 | P. Luci David | Executive | Purchase | 2,083 | $12.00 | $25.0K | |
| Mar 18, 2014 | G. Shawah Robert | Executive | Purchase | 500 | $12.00 | $6.0K | |
| Mar 18, 2014 | L. Harrison Thomas | Executive | Purchase | 2,000 | $12.00 | $24.0K | |
| Mar 18, 2014 | H. Dean Jack | Executive | Purchase | 2,083 | $12.00 | $25.0K | |
| Mar 18, 2014 | J. Coughlin Christopher | Executive | Purchase | 2,083 | $12.00 | $25.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 8 | $182.0K | 100.0% |
Insiders at Dipexium Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 7 insiders making 8 transactions totaling $182.0K in purchases versus $0 in sales, the net buying activity of $182.0K signals strong executive confidence. Jack H. Dean (Executive) leads the buying activity with $52.0K in transactions across all time.